Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: implications for immunotherapy of autoimmune and allergenic disorders-Reference-Cited by-同舟云学术

Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: implications for immunotherapy of autoimmune and allergenic disorders

Published:2019-05-24 Issue:7 Volume:15 Page:701-706
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Seledtsov Victor I.¹,Seledtsova Galina V.²

Affiliation:

1. Center for Medical Biotechnologies, lmmanuel Kant Baltic Federal University, Kaliningrad, Russia

2. Laboratory for Cellular Technologies, Institute for Fundamental and Clinical Immunology, Novosibirsk, Russia

Funder

funded

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2019.1617698

Reference36 articles.

1. Heterogeneity and plasticity of T helper cells

2. A Possible Role for Idiotype/Anti-idiotype B–T Cell Interactions in Maintaining Immune Memory

3. Autoimmune effector memory T cells: the bad and the good

4. Resident memory T cells in human health and disease

5. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-based, multifaceted inactivation of pathogenic T lymphocytes in treating autoimmune diseases;Exploration of Immunology;2023-10-30

2. Tackling cancer cell dormancy: Insights from immune models, and transplantation;Seminars in Cancer Biology;2022-01

3. GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma;PeerJ;2021-05-11

4. Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer;Expert Opinion on Biological Therapy;2020-10-03

5. Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells;European Journal of Pharmacology;2020-07